# Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis

> **NCT04297839** · PHASE3 · SUSPENDED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Hemodialysis Complication
- Acute Kidney Injury
- Anticoagulant Toxicity

## Interventions

- **DRUG:** Citrate Anticoagulation Solution
- **DRUG:** Control Group (heparin or continuous saline)

## Key facts

- **NCT ID:** NCT04297839
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-02-12
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** DUE TO CORONAVIRUS DISEASE, ACTIVITIES INTHE HOSPITAL ARE SUPRESSED
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04297839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04297839, "Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04297839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*